Introduction
Bone metastases are the major cause of morbidity and mortality for patients with prostate cancer. In order to metastasise, malignant cells need to invade through endothelial barriers. We have reported previously that primary human prostatic epithelial cells from patients with carcinoma of the prostate (CaP) or benign prostatic hyperplasia (BPH) showed preferential binding to human bone marrow endothelium compared to control endothelium. In addition, they demonstrated an accelerated growth rate within bone marrow stromal co-cultures. We have extended these studies to look at the motility and invasive nature of malignant versus non-malignant prostatic epithelial cells.
Methods and Results
In an indirect co-culture assay, bone marrow endothelium and bone marrow stroma induced the migration of the malignant PC-3 cell line through matrigel coated invasion chambers whilst the non-malignant cell lines PNT2-C2 demonstrated no invasive ability. Preliminary data indicate that primary human CaP (n 3) epithelial cells are invasive, however, BPH (n 3) epithelial cells are not. GFP-transfected PC-3 cells were also observed to bind to and migrate through bone marrow endothelial barriers grown on collagen coated glass cover slips but not to human umbilical vein endothelial cells. Direct co-culture of PC-3 cells seeded onto bone marrow endothelial monolayers grown on top of cell culture inserts (8 mm pore size) showed co-migration of bone marrow endothelial cells along with the invading PC-3 cells in response to bone marrow stoma.
Conclusions
These observations imply that extravasated prostate tumour cells may induce angiogenesis from the capillaries from which they have extravasated by recruiting endothelial cells, leading to the perfusion of the metastatic tumour aiding its establishment and growth. Our data suggest that the potential invasive ability of a circulating prostatic epithelial cell may be the key element to its successful implantation and growth within the skeleton.
